RTI Biologics (RTIX) Signs Spinal Allograft Implant Supply Agreement
Tweet
Share
E-mailGet Alerts RTIX Hot Sheet
Join SI Premium – FREE
RTI Biologics Inc. (Nasdaq: RTIX) has signed an agreement to provide spinal allograft implants to Alphatec Spine, Inc.
Under the agreement, which is effective immediately and has a three year term with the option to renew, RTI will process allograft implants for use in spine made from assembled cortical allograft.
Under the agreement, which is effective immediately and has a three year term with the option to renew, RTI will process allograft implants for use in spine made from assembled cortical allograft.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Getty Realty discloses separation terms for departing accounting officer
- Simmons Bank chief data officer Lisa Hunter to retire
- LiveRamp shrinks board to six directors after resignation
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
